JSM 2013 Home
Online Program Home
My Program

Keyword Search

Legend: Palais des congrès de Montréal = CC, Le Westin Montréal = W, Intercontinental Montréal = I
A * preceding a session name means that the session is an applied session.
A ! preceding a session name means that the session reflects the JSM meeting theme.
Keyword Search Criteria: Multiplicity returned 12 record(s)
Sunday, 08/04/2013
A Resampling-based Ensemble Tree Method to Identify Patient Subgroups with Enhanced Treatment Effect
Chakib Battioui, Eli Lilly & Company; Lei Shen, Eli Lilly & Company; Stephen J. Ruberg, Eli Lilly & Company
4:25 PM

Monday, 08/05/2013
Multiplicity Adjustment in Bioequivalence Using Two One-Sided Tests (TOST)
Steven Hua, Pfizer Research; Siyan Xu, Boston University; Ronald Menton, Pfizer Inc.
11:05 AM

Indirect Sampling in Case of Asymmetrical Link Structures
Torsten Harms, ISS Hamburg, Int. Business School
3:35 PM

Tuesday, 08/06/2013
Confirmatory Subgroup Analysis: Multiple Testing Approaches
Alexei Dmitrienko, Quintiles
8:55 AM

Weighting Methods for a Study of Men Who Have Sex with Men (MSM3)
Ronaldo Iachan, ICF International; Teresa Finlayson, CDC; Cyprian Wejnert, CDC; Binh Le, CDC; Gabriela Paz-Bailey, CDC; Tonja Kyle, ICF
9:35 AM

A Regression Approach to Penalty Analysis to Assess the Relative Importance of JAR Attributes
Jason Parcon, PepsiCo
11:35 AM

Wednesday, 08/07/2013
Bayesian Multiple Biomarker Subgroup Selection
Zhaowei Hua, Millennium: The Takeda Oncology Company; Mingxiu Hu, Millennium: The Takeda Oncology Company; Chuanhua Xing, Boston University
11:35 AM

Comparison Between Tree Gatekeeping Procedure and Graphical Approach in a Pivotal Clinical Trial with Multiple Objectives and Multiple Endpoints
Masakazu Fujiwara, SHIONOGI & CO., LTD.; Hideaki Watanabe, SHINOGI CO & LTD
2:05 PM

Multiplicity Adjustment Incorporating Correlation and Fallback
Lyrica Liu, Amgen Inc.; Yining Ye, Amgen Inc.; Bin Yao, Amgen Inc.; Amy Xia, Amgen
2:35 PM

Simulations to Evaluate the Impact of Multiplicity Adjustment Procedure Selection in Clinical Trial Design
Bidan Huang, AbbVie; Yaqin Wang, AbbVie Inc.
2:50 PM

A Two-Stage Testing Strategy for Demonstrating Efficacy in Replicate Trials
Chengxing Lu, Novartis; Tony Chen, Novartis
3:20 PM

Thursday, 08/08/2013
Multiplicity in Bioequivalence Trials: Multiple Formulation and Multiple Stage Designs
Lihui Zhao, Novartis Oncology; Cheng Zheng, Novartis Oncology; Jixian (Jason) Wang, Novartis Oncology
11:15 AM




2013 JSM Online Program Home

For information, contact jsm@amstat.org or phone (888) 231-3473.

If you have questions about the Continuing Education program, please contact the Education Department.

The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.

ASA Meetings Department  •  732 North Washington Street, Alexandria, VA 22314  •  (703) 684-1221  •  meetings@amstat.org
Copyright © American Statistical Association.